This inventor holds 2 USPTO granted patents. Top assignees: Johns Hopkins University, Kabushiki Kaisha Toshiba, Toshiba Medical Systems Corporation. Active years: 2018-2022.
Location History:
- Baltimore, MD (US) (2018)
- Red Lion, PA (US) (2022)
Company Filing History:
2 out of 3,794 
1 out of 53,226 
1 out of 2,018 
Years Active: 2018-2022
Title: Scott Patrick Robertson: Innovator in Treatment Plan Risk Analysis
Introduction
Scott Patrick Robertson is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical technology, particularly in the area of treatment plan risk analysis. With a total of 2 patents, Robertson's work focuses on improving patient outcomes through innovative methodologies.
Latest Patents
Robertson's latest patents include a "Method, system and computer-readable media for treatment plan risk analysis." This invention provides a comprehensive approach to analyzing treatment risks by utilizing feature data from prior patients. It generates a distribution of dose points and calculates probabilities of toxicity and treatment failure, ultimately formulating a treatment plan that minimizes risks. Another significant patent is the "Method and apparatus for determining treatment region and mitigating radiation toxicity." This apparatus predicts radiation toxicity to organs-at-risk and iteratively modifies treatment contours to ensure safety and efficacy.
Career Highlights
Throughout his career, Robertson has worked with prestigious organizations such as Johns Hopkins University and Toshiba Corporation. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Robertson has collaborated with notable professionals in his field, including Todd R McNutt and Joseph L Moore. These collaborations have further enhanced his research and development efforts.
Conclusion
Scott Patrick Robertson is a distinguished inventor whose work in treatment plan risk analysis has the potential to transform patient care. His innovative patents and collaborations reflect his commitment to advancing medical technology and improving health outcomes.